Name | Mitotic interactor and substrate of PLK1 | ||
UniProt ID | MISP_HUMAN | ||
Gene Name | MISP | ||
Gene ID | 126353 | ||
Synonyms |
MISP, C19orf21, MISP1
|
||
Sequence |
MDRVTRYPILGIPQAHRGTGLVLDGDTSYTYHLVCMGPEASGWGQDEPQTWPTDHRAQQG
VQRQGVSYSVHAYTGQPSPRGLHSENREDEGWQVYRLGARDAHQGRPTWALRPEDGEDKE MKTYRLDAGDADPRRLCDLERERWAVIQGQAVRKSSTVATLQGTPDHGDPRTPGPPRSTP LEENVVDREQIDFLAARQQFLSLEQANKGAPHSSPARGTPAGTTPGASQAPKAFNKPHLA NGHVVPIKPQVKGVVREENKVRAVPTWASVQVVDDPGSLASVESPGTPKETPIEREIRLA QEREADLREQRGLRQATDHQELVEIPTRPLLTKLSLITAPRRERGRPSLYVQRDIVQETQ REEDHRREGLHVGRASTPDWVSEGPQPGLRRALSSDSILSPAPDARAADPAPEVRKVNRI PPDAYQPYLSPGTPQLEFSAFGAFGKPSSLSTAEAKAATSPKATMSPRHLSESSGKPLST KQEASKPPRGCPQANRGVVRWEYFRLRPLRFRAPDEPQQAQVPHVWGWEVAGAPALRLQK SQSSDLLERERESVLRREQEVAEERRNALFPEVFSPTPDENSDQNSRSSSQASGITGSYS VSESPFFSPIHLHSNVAWTVEDPVDSAPPGQRKKEQWYAGINPSDGINSEVLEAIRVTRH KNAMAERWESRIYASEEDD |
||
Pathway Map | MAP LINK | ||
T.C. Number | 1.A.14.3.14; 1.C.39.9.5; 8.A.67.1.4 | ||
KEGG ID | hsa126353 | ||
Pfam | PF15304 |
Pair Name | Theaflavin 3,3'-digallate, Trastuzumab | |||
Phytochemical | Theaflavin 3,3'-digallate | |||
Drug | Trastuzumab | |||
Disease Info | [ICD-11: 2B72] | Gastric cancer | Investigative | |
Regulate Info | Down-regulation | Mitotic interactor and substrate of PLK1 | Phosphorylation | |
Result | These findings suggest an aberrant mitotic HER2-SHCBP1-PLK1 axis underlies trastuzumab sensitivity and offer a new strategy to combat gastric cancer. |